Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.
How do we ensure the population in a study best reflects the people who will get a medicine in the real world?
advertisement
STAT will bring together a panel of leading experts to discuss the best solutions-based approaches.
Featured speakers:
- LaShell Robinson,senior director, head of diversity, equity & inclusion in clinical research, Takeda
- Ramita Tandon, chief clinical trials officer, Walgreens
- Vindell Washington, M.D., M.S., MS.c, chief clinical officer of care and director of Health Equity Center of Excellence, Verily
- Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)
- Jennifer Cullingford, vice president, customer success, OneStudyTeam (sponsor speaker)
Sponsored By
Previous article：
FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial
Next article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： BioMarin wins approval for gene therapy to treat hemophilia A
